definiens: shall mean the IROFULVEN compositio n and/or any pharmaceutically - active formulations of IROFULVEN in one or more patents listed in Exhib it A, ( ii ) together with rights in technical inform ation recorded in the form of drawings, plans, specificat ion, diagrams, trade secrets as defined by the Unif orm Trade Secrets Act and other data relating to the manufact ure, design and improvement of the IROFULVEN compos ition, but excluding IROFULVEN when bound directly or via a linker to all of the foregoing conjugates : an ant ibody, antibody fragment, peptide, growth factor, receptor proteins, receptor binding entity, lipids, liposom al particles, nanoparticles, PEG carriers, steroids, proteins, to xins, or another drug conjugate ( hereinafter ) . For clarity COMPOUND does not include all of the forego ing : illudin bound directly or via a linker to a Co njugate or acylfulvene bound directly or via a linker to a Con jugate, including an illudin analog bound directly or via a linker to a Conjugate, or acylfulvene analog bound directl y or via a linker to a Conjugate